[In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates]. 1985

C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani

A total of 274 recently isolated Gram-positive e Gram-negative strains have been tested. The method used for the determination of the minimal inhibitory concentration of the antibiotics was by agar dilution and the minimal bactericidal concentrations were determined by "replica plating" system. All strains demonstrated a good sensitivity, above all, to Norfloxacin which inhibited Gram-positive bacteria at the concentration of 3.12 micrograms/ml and, concerning Gram-negative, at the concentration of 0.10 microgram/ml for K.E.S. group, 0.19 microgram/ml for Escherichia coli, 6.25 micrograms/ml for Proteus sp and 1.56 microgram/ml for Pseudomonas aeruginosa. Also with the other antibiotics we obtained good results especially with Nitrofurantoin concerning Enterococcus and Ceftazidime concerning all the strains. On the basis of these results we can conclude that Norfloxacin is one of the most active antibiotics among those used against strains implicated in urinary infections.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D011511 Proteus A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani
January 1997, Chemotherapy,
C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani
September 1993, Antimicrobial agents and chemotherapy,
C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani
April 1988, Microbiologica,
C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani
August 2001, Diagnostic microbiology and infectious disease,
C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani
November 2009, Antimicrobial agents and chemotherapy,
C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani
January 1985, Giornale italiano di chemioterapia,
C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani
April 2017, International journal of antimicrobial agents,
C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani
June 1984, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani
January 1985, Drugs,
C Mancini, and M I Brenciaglia, and M C Ghezzi, and A Giordano, and C Nazzari, and P Cipriani
January 1988, Acta clinica Belgica,
Copied contents to your clipboard!